Inactive Instrument

Highlights Rise Life Science Corp Toronto S.E.

Equities

MOM

CA55028M1032

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Britannia Completes "Go Public" Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.	21-11-15	AQ
Britannia Bud Canada Holdings Inc. completed the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-11-11	CI
RISE Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	21-11-01	CI
Scientus Pharma Inc. cancelled the acquisition of RISE Life Science Corp. in a reverse merger transaction.	21-10-29	CI
RISE Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2021	21-07-29	CI
Britannia Enters into Definitive Agreement with Rise Life Science to "Go Public" via Reverse Takeover of Rise Life Science	21-05-03	NE
Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2021	21-04-28	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2020	21-03-29	CI
Britannia Bud Canada Holdings Inc. entered into a Letter of intent to acquire RISE Life Science Corp. in a reverse merger transaction.	21-01-21	CI
Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2020	20-10-30	CI
Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2020	20-07-28	CI
Scientus Pharma Inc. entered into a binding letter agreement to acquire RISE Life Science Corp. for CAD 0.3 million in a reverse merger transaction.	20-04-12	CI
Rise Life Science Corp. Reports Earnings Results for the Full Year Ended November 30, 2019	20-04-05	CI
Rise Life Science Corp. Reports Earnings Results for the Third Quarter Ended August 31, 2019	19-10-29	CI
Rise Life Science Corp. Reports Earnings Results for the Second Quarter Ended May 31, 2019	19-07-30	CI
RISE Life Science Corp. Launches Retail Location on Main Street in Santa Monica, California	19-06-14	CI
RISE Life Science Corp. Provides Operational Update	19-04-30	CI
Rise Life Science Corp. Reports Earnings Results for the First Quarter Ended February 28, 2019	19-04-29	CI
RISE Life Science Corp. Announces Hemp-Based CBD Product Approval for Distribution in Mexico	19-04-17	CI
RISE Life Science Corp. Announces Two New Oral Spray Formulas to Its Suite of Product Offerings	19-04-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rise Life Science Corp Toronto S.E.

Equities

MOM

CA55028M1032

Highlights

Filters